Bilimsel çalışmalar

Doç. Dr. Ezgi Değerli

38 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy

    Medicina, 2026

    DOI 10.3390/medicina62010200 PMID 41597486 Açık erişimli tam metinKaynak: OpenAlex

  2. Pathological Response and Survival Outcomes Following Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer: Real-world Experience

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-3-9 Açık erişimli tam metinKaynak: OpenAlex

  3. Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey

    OncoTargets and therapy, 2026

    DOI 10.2147/ott.s622194 PMID 42644128 Açık erişimli tam metinKaynak: Europe PMC

  4. Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma

    Tumori, 2026

    DOI 10.1177/03008916261490843 PMID 42847292 Kaynak: Europe PMC

  5. Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy

    Medicina, 2025

    DOI 10.3390/medicina61071168 PMID 40731799 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. Clinical Analysis of Multiple Primary Malignant Tumors: A Single-Center Experience

    Cerrahpasa Medical Journal, 2025

    DOI 10.5152/cjm.2025.25022 Açık erişimli tam metinKaynak: OpenAlex

  7. Effects of immune related adverse events and corticosteroids on the outcome of patients treated with immune checkpoint inhibitors

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-91102-z PMID 39984593 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Docetaxel-induced severe neuropathy, a case of breast cancer with GTSP1 polymorphism

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2025

    DOI 10.1177/10781552241279831 PMID 39195359 Kaynak: Europe PMC

  9. Neutrophil–Lymphocyte Ratio and Prognostic Nutritional Index Predict Prognosis for Definitive Chemoradiotherapy in Cervical Cancer

    Indian Journal of Gynecologic Oncology, 2025

    DOI 10.1007/s40944-025-01029-6 Kaynak: OpenAlex

  10. The Relationship Between Changes in the Neutrophil-Lymphocyte Ratio (NLR) and Radiological Progression in Cervical Cancer

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2025.59254 Açık erişimli tam metinKaynak: OpenAlex

  11. The Relationship Between Hemoglobin to Albumin Ratio and Disease-Free Survival in Patients with Locally Advanced Nasopharyngeal Cancer Treated with Chemoradiotherapy

    Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2025

    DOI 10.4274/bmj.galenos.2025.2025.3-8 Açık erişimli tam metinKaynak: OpenAlex

  12. Ghrelin Levels and Disease Localization in Inflammatory Bowel Disease: A Correlation Study

    Sakarya Medical Journal, 2025

    DOI 10.31832/smj.1679691 Açık erişimli tam metinKaynak: OpenAlex

  13. Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy

    Medicina, 2024

    DOI 10.3390/medicina60122103 PMID 39768982 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  14. Obesity Is an Independent Prognostic Factor That Reduced Pathological Complete Response in Operable Breast Cancer Patients

    Medicina, 2024

    DOI 10.3390/medicina60121953 PMID 39768835 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-13064-1 PMID 39448928 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  16. Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors

    Clinical & Translational Oncology, 2024

    DOI 10.1007/s12094-024-03696-x PMID 39225958 3 atıf (Europe PMC) Kaynak: OpenAlex

  17. Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer

    Tumori Journal, 2024

    DOI 10.1177/03008916241291989 PMID 39506383 Açık erişimli tam metinKaynak: OpenAlex

  18. Apelin Levels According to the Site of Involvement in Inflammatory Bowel Diseases

    Experimed, 2024

    DOI 10.26650/experimed.1494644 Açık erişimli tam metinKaynak: OpenAlex

  19. Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.64606 Açık erişimli tam metinKaynak: OpenAlex

  20. Prognostic factors in Kaposi sarcoma, single centre experience

    The Australasian journal of dermatology, 2024

    DOI 10.1111/ajd.14309 PMID 38760927 1 atıf (Europe PMC) Kaynak: Europe PMC

  21. Nivolumab Efficacy and Safety in Cancer Patients with Renal Dysfunction

    Medical Bulletin of Haseki, 2024

    DOI 10.4274/haseki.galenos.2024.9916 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  22. Impact of Tumor Location on the Clinicopathologic and Oncologic Outcomes of Stage 1-3 Colon Cancer

    Eurasian Journal of Medical Investigation, 2024

    DOI 10.14744/ejmi.2024.24868 Kaynak: OpenAlex

  23. Major and minor salivary gland cancers: A multicenter retrospective study

    Head & Neck, 2023

    DOI 10.1002/hed.27376 PMID 37084179 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  24. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  25. 149P HER2-low status and response to neoadjuvant chemotherapy in early breast cancer

    ESMO Open, 2023

    DOI 10.1016/j.esmoop.2023.101488 Açık erişimli tam metinKaynak: OpenAlex

  26. Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy

    Journal of chemotherapy (Florence, Italy), 2023

    DOI 10.1080/1120009x.2022.2043514 PMID 35220928 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  27. Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer

    Lung Cancer, 2023

    DOI 10.1016/j.lungcan.2023.107347 PMID 37597304 24 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  28. A single center's experience of the extrapulmonary neuroendocrine carcinomas

    Northern clinics of Istanbul, 2022

    DOI 10.14744/nci.2021.47887 PMID 35340315 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  29. Serum Irisin Levels in Newly Diagnosed Type 2 Diabetes Mellitus and Prediabetic Patients

    Selçuk Tıp Dergisi, 2022

    DOI 10.30733/std.2022.01540 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  30. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID‐19 patients with malignancy: A single‐center experience

    Journal of Medical Virology, 2021

    DOI 10.1002/jmv.27123 PMID 34081337 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  31. Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021

    DOI 10.1177/10781552211066888 PMID 34878367 1 atıf (Europe PMC) Kaynak: ORCID

  32. Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer

    Tumori Journal, 2020

    DOI 10.1177/0300891620953468 PMID 32935638 4 atıf (Europe PMC) Kaynak: OpenAlex

  33. Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma

    Melanoma Research, 2020

    DOI 10.1097/cmr.0000000000000678 PMID 32898388 7 atıf (Europe PMC) Kaynak: OpenAlex

  34. A rare case of cardiac toxicity in a patient with imatinib treatment: Case report

    Journal of Cancer Research and Therapeutics, 2020

    DOI 10.4103/jcrt.jcrt_188_19 PMID 35900559 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  35. KANSER HASTALARINDA UYKU KALİTESİNİ ETKİLEYEN FAKTÖRLER

    Namık Kemal Tıp Dergisi, 2020

    DOI 10.37696/nkmj.674879 Açık erişimli tam metinKaynak: OpenAlex

  36. Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155220964895 PMID 33040673 Kaynak: OpenAlex

  37. Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz449.007 Açık erişimli tam metinKaynak: OpenAlex

  38. Temperament characteristics of bipolar patients on lithium therapy and relationship with lithium treatment response

    European Neuropsychopharmacology, 2016

    DOI 10.1016/s0924-977x(16)31417-1 Kaynak: OpenAlex